Deferred Consent in Neonatal Clinical Research: Why, When, How?

Area of Science:

• Neonatal research ethics
• Clinical trial methodology
• Emergency medicine

Background:

• Deferred consent is emerging as a method to enhance recruitment in neonatal research, particularly for emergency therapies.
• It may reduce parental burden and yield stronger evidence when clinical equipoise exists.
• Ethical challenges and varying jurisdictional guidelines necessitate careful consideration.

Purpose of the Study:

• To explore the ethical justification and practical implementation of deferred consent in neonatal research.
• To present a framework for deferred consent trials in neonates, including drug and non-drug interventions.
• To incorporate the perspectives of healthcare providers and parents on deferred consent practices.

Main Methods:

• Review of deferred consent principles and ethical considerations in neonatal research.
• Presentation of a framework derived from Australian deferred consent neonatal trials.
• Inclusion of stakeholder (provider and parent) views on implementation strategies.

Main Results:

• Deferred consent can ethically facilitate research in emergency neonatal care, improving recruitment and evidence quality.
• A framework for conducting deferred consent trials in neonates has been developed.
• Stakeholder engagement is vital for successful and ethical implementation.

Conclusions:

• Deferred consent offers a viable ethical approach to neonatal research, especially in emergencies.
• Careful planning and consideration of stakeholder perspectives are essential for its appropriate use.
• Further research and clear guidelines are needed to optimize deferred consent practices.